Searchlight Pharma of Canada mentions that it has Nextstellis...

Searchlight Pharma of Canada mentions that it has Nextstellis under regulatory review at Health Canada.
This was reported on Yahoo Finance overnight with an excerpt set out below.

Let's hope the Mayne Pharma FDA approval is not too far away.


******************************************************************************************************
"We are excited to further grow our women's health portfolio with this first-in-class medication for the treatment of HSDD in Canada," said Mark Nawacki, President and CEO of Searchlight Pharma. "Since our inception, we have focused our commercial energies on women's health, and have built one of the leading Canadian commercial platforms addressing a broad spectrum of conditions impacting Canadian women.  Addyi represents the newest addition to our deep and synergistic therapeutic portfolio that includes market-leading brands such as Mona Lisa^® IUDs for contraception, Estragyn^™ Vaginal Cream for the treatment of VVA, Divigel^® for the treatment of menopausal symptoms, and our combined oral contraceptive candidate Nextstellis^®, which is based on the unique, native estrogen Estetrol (E4) and which is currently undergoing regulatory review at Health Canada."